期刊文献+

腹腔镜卵巢切除术在绝经前乳腺癌辅助治疗中的应用(附21例报告) 被引量:1

The application of laparoscopic ovariectomy in the adjuvant therapy of premenopausal breast cancer:with a report of 21 cases
下载PDF
导出
摘要 目的:探讨腹腔镜卵巢去势术辅助治疗绝经前乳腺癌的应用价值。方法:应用腹腔镜施行卵巢去势术21例,主要用于辅助治疗绝经前乳腺癌患者。结果:术后患者均恢复良好,未发生手术并发症,术后第2天均自行肛门排气。结论:对部分无法行药物性卵巢去势的患者,腹腔镜卵巢去势术是很好的选择。 Objective:To investigate the application of laparoscopic ovariectomy in the adjuvant treatment of premenopausal breast cancer. Methods: Twenty-one cases of laparoseopic ovarieetomy were applied mainly for pre-menopausal breast cancer patients as adjuvant therapy. Results:All patients recovered well after operation, no postoperative complications occurred, anal exsufflation occurred on the second day after operation. Conclusions : For some patients can accept drug castration due to personal reasons, laparoscopic ovariectomy is a good choice.
出处 《腹腔镜外科杂志》 2009年第7期551-552,共2页 Journal of Laparoscopic Surgery
关键词 腹腔镜术 卵巢切除术 乳腺肿瘤 肿瘤辅助疗法 Laparoscopy Ovariectomy Breast neoplasms Neoadjuvant therapy
  • 相关文献

参考文献4

二级参考文献11

  • 1[2]Nahboltz J M, Buzdar A, Pollak M, et al. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: Results of a North American multicenter randomized trial. Arimidex Study Group. J Clin Oncol,2000, 18 (22) :3758
  • 2[3]Bonneterre J, Thurliman B, Robertson J F R, et al. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study. J Clin Oncol, 2000, 18 (22) :3748
  • 3[5]Patrick Therasse, Susan G, Arbuck, et al. New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Insitute, 2000, 92 (3) : 205
  • 4[8]Buzdar A, Jonat W, Howell A, et al. Significant improved survival with arimidex (anastrozole) vs megestrol acetate in postmenopausal women with advanced breast cancer: Results of overview analysis of two phase trials. J Clin Oncol, 1996, 14:2000
  • 5[9]Buzdar A, Jonat W, Howell A, et al. Anatrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: Results of a survial update based on a combined analysis of data from two, mature phase Ⅲ trials.Cancer, 1998, 83:1142
  • 6[10]Taylor CW, Green S, Dalton WS, et al. Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer. J ClinOncol, 1998, 16 (3) :993
  • 7[11]Michaud LB, Buzdar Au. Complete estrogen blockade for the treatment of metastatic and early stage breast cancer. Drugs Aging, 2000, 16 (4) :261
  • 8[12]Milla-Santos A, Milla L, Portella J, et al. A randomized trial of goserelin (zolade.xTm ) + tamoxifen versus goserelin + anastrozole (arimidexTm) in pre/perimenopausal patients with hormone dependent advanced breast cancer. Breast Cancer Res Treat, 2000:64 (1) :Abstract 173
  • 9江泽飞,宋三泰.乳腺癌内分泌治疗的新思路和新策略[J].中华肿瘤杂志,2003,25(4):410-411. 被引量:40
  • 10宋三泰,江泽飞.乳腺癌内科治疗的基本思路[J].中国实用外科杂志,2003,23(10):580-582. 被引量:10

共引文献21

同被引文献7

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部